Last updated: January 25, 2021
Sponsor: Virginia Commonwealth University
Overall Status: Completed
Phase
N/A
Condition
Metabolic Syndrome
Stress
Vascular Diseases
Treatment
N/AClinical Study ID
NCT03542240
HM20012060
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Based on National Institutes of Health (NIH) definition of Metabolic syndrome, thesubject must meet at least 3 of the following criteria: A. Waist Circumference: Female ≥ 88 cm, Male ≥ 102 cm B. Blood Pressure: ≥ 130/85mm/Hg and/or treatment with blood pressure lowering medication C. Impaired fastingglucose or HbA1c (fasting glucose ≥ 100 mg/dl or HgA1c ≥ 5.7 D. HDL-C: Females< 50mg/dl, Males < 40 mg/dl E. Triglycerides ≥ 150 mg/dl
- Willing and able to comply with the study protocol
Exclusion
Exclusion Criteria:
- Diabetes
- Established cardiovascular disease
- Pre-existing liver disease other than NAFLD
- Chronic kidney disease (Stage 4 and 5)
- Rheumatological disease
- Active malignancy
- Alcohol consumption greater than 7 drinks per week for females and greater than 14drinks per week for males
- Current use of metformin and/or steroids
- Curcumin supplementation
- Females of child-bearing potential (NOT of child-bearing potential is defined as s/physterectomy or post-menopausal.)
- Prisoners/wards of the state and individuals with limited English proficiency
Study Design
Total Participants: 15
Study Start date:
September 19, 2018
Estimated Completion Date:
November 13, 2020
Study Description
Connect with a study center
Virginia Commonwealth University
Richmond, Virginia 23298
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.